Skip to main content

Huang Jane's Form 4 filing

BeOne Medicines Ltd. (ONC) · filed Sep 2, 2021

Accession no.
0001651308-21-000188
Filed
Sep 2, 2021
Trade date
Aug 31-Sep 2, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions. Open-market sales total $346.6K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Huang JaneCIK 0001683913Officer (CMO, Hematology)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 31, 2021Ordinary SharesAGrant or awardAcquired+7,163$0.00$0305,824Direct
Sep 1, 2021Ordinary SharesAGrant or awardAcquired+7,124$0.00$0312,948Direct
Aug 31, 2021American Depositary SharesAGrant or awardAcquired+542$0.00$0542Direct
Sep 1, 2021American Depositary SharesSSaleDisposed−542$310.53−$168,307.260Direct
Sep 1, 2021American Depositary SharesAGrant or awardAcquired+545$0.00$0545Direct
Sep 2, 2021American Depositary SharesSSaleDisposed−545$327.18−$178,313.10Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)